查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1489263

全球电脑模拟药物发现市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global In-Silico Drug Discovery Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2032年，全球电脑模拟药物发现市场的市场规模将从2023年的30.997亿美元达到近83.3005亿美元，2024-2032年研究期间的复合年增长率为11.61%。

电脑模拟药物发现涉及使用电脑模拟和计算方法来识别和开发新药物。此方法利用生物资讯学、分子建模和资料分析来预测候选药物如何与生物标靶相互作用。电脑技术可以筛选大量的化合物库，识别潜在的候选药物，优化先导化合物，并预测其药物动力学和毒理学特征。这种方法显着加速了药物发现过程，降低了成本，并最大限度地减少了大量实验室工作的需要。

市场动态

电脑模拟药物发现市场是由对更有效率、更具成本效益和更快的药物发现过程的需求所推动的。计算生物学和生物资讯学的进步显着增强了电脑模拟药物发现的能力，使研究人员能够预测药物交互作用、优化候选药物并在开发早期识别潜在的副作用。传统药物开发成本的不断上升以及针对多因素疾病的复杂性日益增加，使得 In-Silico 方法更具吸引力。此外，对将计算方法整合到药物开发过程中的监管支持鼓励更多的製药公司采用这些技术。高效能运算资源和复杂软体工具的不断增加进一步推动了电脑模拟药物发现市场的成长。然而，计算复杂性和资料准确性问题可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球电脑药物发现市场的每个细分市场进行了包容性评估。电脑模拟药物发现产业的成长和趋势为这项研究提供了整体方法。

市场区隔

电脑模拟药物发现市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

  • 软体作为服务
  • 软体
  • 咨询即服务

按工作流程

  • 临床前测试
  • 发现
  • 临床测试

按目标治疗领域

  • 代谢紊乱
  • 爱滋病
  • 传染性疾病
  • 肌肉骨骼疾病
  • 精神错乱
  • 神经系统疾病
  • 肿瘤疾病

按最终用户

  • 合约研究组织
  • 製药和生物製药公司
  • 学术及研究机构

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的电脑模拟药物发现市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。电脑模拟药物发现市场的主要参与者包括 Charles River Laboratories、Curia Global Inc.（美国 Certara）、Chemical Computer Group ULC、GenScript、Sygnature Discovery、Abzena Ltd.、BioNTech SE、Creative Biostruct。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：电脑模拟药物发现 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 依工作流程进行市场吸引力分析
    • 按目标治疗领域分類的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球电脑模拟药物发现市场分析：按产品

  • 概述（按产品）
  • 按产品分类的历史和预测资料分析
  • 软体作为服务
  • 软体
  • 咨询即服务

第 6 章：全球电脑模拟药物发现市场分析：按工作流程

  • 按工作流程概述
  • 按工作流程进行历史和预测资料分析
  • 临床前测试
  • 发现
  • 临床测试

第 7 章：全球电脑模拟药物发现市场分析：按目标治疗领域

  • 按目标治疗领域概述
  • 按目标治疗领域进行的历史和预测数据分析
  • 代谢紊乱
  • 爱滋病
  • 传染性疾病
  • 肌肉骨骼疾病
  • 精神错乱
  • 神经系统疾病
  • 肿瘤疾病

第 8 章：全球电脑模拟药物发现市场分析：按最终用户分类

  • 最终用户概述
  • 最终用户的历史和预测数据分析
  • 合约研究组织
  • 製药和生物製药公司
  • 学术及研究机构

第 9 章：全球电脑模拟药物发现市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：电脑模拟药物发现公司的竞争格局

  • 电脑模拟药物发现市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Charles River Laboratories
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Curia Global Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Certara USA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Creative Biostructure
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Chemical Computing Group ULC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GenScript
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sygnature Discovery
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Abzena Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BioNTech SE
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114720

The global demand for In-Silico Drug Discovery Market is presumed to reach the market size of nearly USD 8330.05 Million by 2032 from USD 3099.7 Million in 2023 with a CAGR of 11.61% under the study period 2024-2032.

In-silico drug discovery involves using computer simulations and computational methods to identify and develop new pharmaceuticals. This approach utilizes bioinformatics, molecular modeling, and data analysis to predict how drug candidates interact with biological targets. In-silico techniques can screen vast libraries of compounds, identify potential drug candidates, optimize lead compounds, and predict their pharmacokinetic and toxicological profiles. This method significantly accelerates the drug discovery process, reduces costs, and minimizes the need for extensive laboratory work.

MARKET DYNAMICS

The in-silico drug discovery market is driven by the need for more efficient, cost-effective, and faster drug discovery processes. Advances in computational biology and bioinformatics have significantly enhanced the capabilities of in-silico drug discovery, enabling researchers to predict drug interactions, optimize drug candidates, and identify potential side effects early in development. The rising cost of traditional drug development and the increasing complexity of targeting multifactorial diseases make In-Silico approaches more attractive. Additionally, regulatory support for integrating computational methods in drug development processes encourages more pharmaceutical companies to adopt these technologies. The growing availability of high-performance computing resources and sophisticated software tools further propels the growth of the in-silico drug discovery market. However, computational complexities and data accuracy concerns may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of In-Silico Drug Discovery. The growth and trends of In-Silico Drug Discovery industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the In-Silico Drug Discovery market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Software-as-a-Service
  • Software
  • Consultancy-as-a-Service

By Workflow

  • Pre-Clinical Tests
  • Discovery
  • Clinical Tests

By Target Therapeutic Area

  • Metabolic disorders
  • HIV
  • Infectious diseases
  • Musculoskeletal disorders
  • Mental disorders
  • Neurological disorders
  • Oncological disorders

By End User

  • Contract Research Organizations
  • Pharmaceutical and Biopharmaceutical Companies
  • Academic and Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In-Silico Drug Discovery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In-Silico Drug Discovery market include Charles River Laboratories, Curia Global Inc., Certara, USA, Chemical Computing Group ULC, GenScript, Sygnature Discovery, Abzena Ltd., BioNTech SE, Creative Biostructure. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. IN-SILICO DRUG DISCOVERY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Workflow
    • 3.7.3 Market Attractiveness Analysis By Target Therapeutic Area
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Software-as-a-Service Historic and Forecast Sales By Regions
  • 5.4. Software Historic and Forecast Sales By Regions
  • 5.5. Consultancy-as-a-Service Historic and Forecast Sales By Regions

6. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY WORKFLOW

  • 6.1. Overview By Workflow
  • 6.2. Historical and Forecast Data Analysis By Workflow
  • 6.3. Pre-Clinical Tests Historic and Forecast Sales By Regions
  • 6.4. Discovery Historic and Forecast Sales By Regions
  • 6.5. Clinical Tests Historic and Forecast Sales By Regions

7. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY TARGET THERAPEUTIC AREA

  • 7.1. Overview By Target Therapeutic Area
  • 7.2. Historical and Forecast Data Analysis By Target Therapeutic Area
  • 7.3. Metabolic disorders Historic and Forecast Sales By Regions
  • 7.4. HIV Historic and Forecast Sales By Regions
  • 7.5. Infectious diseases Historic and Forecast Sales By Regions
  • 7.6. Musculoskeletal disorders Historic and Forecast Sales By Regions
  • 7.7. Mental disorders Historic and Forecast Sales By Regions
  • 7.8. Neurological disorders Historic and Forecast Sales By Regions
  • 7.9. Oncological disorders Historic and Forecast Sales By Regions

8. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY END USER

  • 8.1. Overview By End User
  • 8.2. Historical and Forecast Data Analysis By End User
  • 8.3. Contract Research Organizations Historic and Forecast Sales By Regions
  • 8.4. Pharmaceutical and Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 8.5. Academic and Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE IN-SILICO DRUG DISCOVERY COMPANIES

  • 10.1. In-Silico Drug Discovery Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF IN-SILICO DRUG DISCOVERY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Charles River Laboratories
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Curia Global Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Certara USA
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Creative Biostructure
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Chemical Computing Group ULC
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. GenScript
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Sygnature Discovery
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Abzena Ltd.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. BioNTech SE
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Software-as-a-Service Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Consultancy-as-a-Service Market Sales By Geography (USD MN)
  • Analysis By Workflow (USD MN)
  • Pre-Clinical Tests Market Sales By Geography (USD MN)
  • Discovery Market Sales By Geography (USD MN)
  • Clinical Tests Market Sales By Geography (USD MN)
  • Analysis By Target Therapeutic Area (USD MN)
  • Metabolic disorders Market Sales By Geography (USD MN)
  • HIV Market Sales By Geography (USD MN)
  • Infectious diseases Market Sales By Geography (USD MN)
  • Musculoskeletal disorders Market Sales By Geography (USD MN)
  • Mental disorders Market Sales By Geography (USD MN)
  • Neurological disorders Market Sales By Geography (USD MN)
  • Oncological disorders Market Sales By Geography (USD MN)
  • Analysis By End User (USD MN)
  • Contract Research Organizations Market Sales By Geography (USD MN)
  • Pharmaceutical and Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic and Research Institutes Market Sales By Geography (USD MN)
  • Global In-Silico Drug Discovery Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In-Silico Drug Discovery Report
  • Market Research Process
  • Market Research Methodology
  • Global In-Silico Drug Discovery Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Workflow
  • Market Attractiveness Analysis By Target Therapeutic Area
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Software-as-a-Service Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Consultancy-as-a-Service Market Sales By Geography (USD MN)
  • Global Market Analysis By Workflow (USD MN)
  • Pre-Clinical Tests Market Sales By Geography (USD MN)
  • Discovery Market Sales By Geography (USD MN)
  • Clinical Tests Market Sales By Geography (USD MN)
  • Global Market Analysis By Target Therapeutic Area (USD MN)
  • Metabolic disorders Market Sales By Geography (USD MN)
  • HIV Market Sales By Geography (USD MN)
  • Infectious diseases Market Sales By Geography (USD MN)
  • Musculoskeletal disorders Market Sales By Geography (USD MN)
  • Mental disorders Market Sales By Geography (USD MN)
  • Neurological disorders Market Sales By Geography (USD MN)
  • Oncological disorders Market Sales By Geography (USD MN)
  • Global Market Analysis By End User (USD MN)
  • Contract Research Organizations Market Sales By Geography (USD MN)
  • Pharmaceutical and Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic and Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.